ValuEngine cut shares of IntriCon (NASDAQ:IIN) from a strong-buy rating to a buy rating in a research report sent to investors on Friday.
IIN has been the topic of a number of other research reports. TheStreet downgraded shares of IntriCon from a b rating to a c+ rating in a research report on Monday, October 1st. BidaskClub downgraded shares of IntriCon from a strong-buy rating to a buy rating in a research report on Tuesday, November 13th. Zacks Investment Research upgraded shares of IntriCon from a hold rating to a buy rating and set a $50.00 target price on the stock in a research report on Wednesday, October 24th. Stifel Nicolaus boosted their target price on shares of IntriCon from $65.00 to $70.00 and gave the company a buy rating in a research report on Friday, September 21st. Finally, Dougherty & Co downgraded shares of IntriCon from a buy rating to a neutral rating and set a $12.00 target price on the stock. in a research report on Tuesday, September 11th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the stock. The stock has a consensus rating of Buy and an average price target of $48.50.
Shares of IntriCon stock traded down $2.07 during trading on Friday, reaching $31.09. 148,501 shares of the company traded hands, compared to its average volume of 186,370. IntriCon has a 1-year low of $16.70 and a 1-year high of $76.80. The company has a market capitalization of $286.53 million, a PE ratio of 107.21, a PEG ratio of 3.84 and a beta of 0.95.
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Navellier & Associates Inc grew its stake in shares of IntriCon by 30.9% in the 2nd quarter. Navellier & Associates Inc now owns 15,142 shares of the technology company’s stock worth $610,000 after acquiring an additional 3,577 shares in the last quarter. Rhumbline Advisers bought a new stake in shares of IntriCon in the 2nd quarter worth $232,000. Mackay Shields LLC bought a new stake in shares of IntriCon in the 2nd quarter worth $963,000. Bank of New York Mellon Corp bought a new stake in shares of IntriCon in the 2nd quarter worth $741,000. Finally, Schwab Charles Investment Management Inc. bought a new stake in shares of IntriCon in the 2nd quarter worth $526,000. Hedge funds and other institutional investors own 59.51% of the company’s stock.
IntriCon Company Profile
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical bio-telemetry devices, hearing healthcare, and professional audio communication devices markets.
Recommended Story: Do stock splits help investors?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.